Would you recommend using chemotherapy based on RxPonder regardless of Oncotype score in a premenopausal patient? Or would you hold chemotherapy since...
New answer by Medical Oncologist at Banner MD Anderson Cancer Center (September 28, 2023)
Since you are citing the RxPONDER study, I assume this is a premenopausal woman over age 50 with N1 node positive disease.In the RxPONDER study, for premenopausal women, the 5...